Related references
Note: Only part of the references are listed.Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent
Giancarlo Ceccarelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
Brandon J. Beddingfield et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Why are vaccines against many human viral diseases still unavailable; an historic perspective?
Gregory A. Tannock et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
Yanxiao Han et al.
ACS NANO (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Paolo Verdecchia et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2
Cheng Wang et al.
GASTROENTEROLOGY (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
Javier A. Jaimes et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
Yuanmei Zhu et al.
JOURNAL OF VIROLOGY (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Ruochen Zang et al.
SCIENCE IMMUNOLOGY (2020)
De novo design of protein peptides to block association of the SARS-CoV-2 spike protein with human ACE2
Xiaoqiang Huang et al.
Aging-US (2020)
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Tianxiao Liu et al.
PHARMACOLOGY & THERAPEUTICS (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection
Carina Conzelmann et al.
ANTIVIRAL RESEARCH (2020)
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
Leonid Yurkovetskiy et al.
CELL (2020)
Extrapulmonary manifestations of COVID-19
Aakriti Gupta et al.
NATURE MEDICINE (2020)
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Antoni G. Wrobel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
Rongsong Ling et al.
PEPTIDES (2020)
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
Mirza S. Baig et al.
DRUGS IN R&D (2020)
Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states
Mert Gur et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Antiviral Peptides as Promising Therapeutics against SARS-CoV-2
Surid Mohammad Chowdhury et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
In-silico design of a potential inhibitor of SARS-CoV-2 S protein
Grijesh Jaiswal et al.
PLOS ONE (2020)
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao et al.
SCIENCE (2020)
A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
Hanjun Zhao et al.
NATURE COMMUNICATIONS (2020)
Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
Amanat Ali et al.
SCIENTIFIC REPORTS (2020)
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino et al.
ACS CENTRAL SCIENCE (2020)
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
Praveen Kumar Tripathi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment
Kerem Terali et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
Arash Keshavarzi Arshadi et al.
FRONTIERS IN ARTIFICIAL INTELLIGENCE (2020)
HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
Dirk Eggink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The SIRAH 2.0 Force Field: Altius, Fortius, Citius
Matias R. Machado et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)
BacMam production and crystal structure of nonglycosylated apo human furin at 1.89Å resolution
Kenneth H. Pearce et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Antiviral peptides as promising therapeutic drugs
Liana Costa Pereira Vilas Boas et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
ATN-161 reduces virus proliferation in PHEV-infected mice by inhibiting the integrin α5β1-FAK signaling pathway
Xiaoling Lv et al.
VETERINARY MICROBIOLOGY (2019)
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Emerging/re-emerging viral diseases & new viruses on the Indian horizon
Devendra T. Mourya et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
Furin-mediated protein processing in infectious diseases and cancer
Elisabeth Braun et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?
Elsa Bodier-Montagutelli et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains
Shuai Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm
Pei Zhou et al.
NUCLEIC ACIDS RESEARCH (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry
Kazuya Shirato et al.
VIROLOGY (2018)
Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides
Pol Arranz-Gibert et al.
SCIENTIFIC REPORTS (2018)
De novo design of a fluorescence-activating β-barrel
Jiayi Dou et al.
NATURE (2018)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
Sakaorat Lertjuthaporn et al.
PLOS PATHOGENS (2018)
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein
Hannah Kleine-Weber et al.
SCIENTIFIC REPORTS (2018)
Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2017)
The SWISS-MODEL Repository-new features and functionality
Stefan Bienert et al.
NUCLEIC ACIDS RESEARCH (2017)
A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity
Huihui Chong et al.
JOURNAL OF VIROLOGY (2017)
The ClusPro web server for protein-protein docking
Dima Kozakov et al.
NATURE PROTOCOLS (2017)
Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus
Yaping Sun et al.
VIRUSES-BASEL (2017)
Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+T lymphocytes
Xueyuan Zhou et al.
BMC MICROBIOLOGY (2016)
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Nan Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank et al.
JOURNAL OF HEPATOLOGY (2016)
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
G. C. P. van Zundert et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
Hanjun Zhao et al.
SCIENTIFIC REPORTS (2016)
A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide Vaccines
Ashesh Nandy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice
Tao Liu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2016)
Beyond RGD: virus interactions with integrins
Hosni A. M. Hussein et al.
ARCHIVES OF VIROLOGY (2015)
MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories
Robert T. McGibbon et al.
BIOPHYSICAL JOURNAL (2015)
AVP-IC50Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50)
Abid Qureshi et al.
BIOPOLYMERS (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Design of a Potent Antibiotic Peptide Based on the Active Region of Human Defensin 5
Cheng Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The I-TASSER Suite: protein structure and function prediction
Jianyi Yang et al.
NATURE METHODS (2015)
Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses
Shweta Tripathi et al.
PLOS ONE (2015)
EPI-X4, a novel endogenous antagonist of CXCR4
Christian Buske et al.
ONCOTARGET (2015)
Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy
Xiaojie Zhu et al.
SCIENTIFIC REPORTS (2015)
Inhibitory activity and molecular mechanism of protegrin-1 against porcine reproductive and respiratory syndrome virus in vitro
Chunhe Guo et al.
ANTIVIRAL THERAPY (2015)
Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases
Antonello Pessi
JOURNAL OF PEPTIDE SCIENCE (2015)
Novel Delivery Systems for Improving the Clinical Use of Peptides
Miia Kovalainen et al.
PHARMACOLOGICAL REVIEWS (2015)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses
Abid Qureshi et al.
NUCLEIC ACIDS RESEARCH (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
Teicoplanin for treating MRSA pneumonia
J. Mukhopadhyay
BMJ-BRITISH MEDICAL JOURNAL (2014)
A Rationally Engineered Anti-HIV Peptide Fusion Inhibitor with Greatly Reduced Immunogenicity
Frances Brauer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Identification of the first synthetic inhibitors of the type II transmembrane serine protease IMPRSS2 suitable for inhibition of influenza virus activation
Daniela Meyer et al.
BIOCHEMICAL JOURNAL (2013)
Airway delivery of peptides and proteins using nanoparticles
Christophe Y. Dombu et al.
BIOMATERIALS (2013)
Antiviral Mechanisms of Human Defensins
Sarah S. Wilson et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus
Jing Gao et al.
JOURNAL OF VIROLOGY (2013)
In Silico Approach for Predicting Toxicity of Peptides and Proteins
Sudheer Gupta et al.
PLOS ONE (2013)
Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium
Eva Boettcher-Friebertshaeuser et al.
PATHOGENS AND DISEASE (2013)
Basics and recent advances in peptide and protein drug delivery
Benjamin J. Bruno et al.
THERAPEUTIC DELIVERY (2013)
A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2
Anna-Winona Struck et al.
ANTIVIRAL RESEARCH (2012)
The biology and therapeutic targeting of the proprotein convertases
Nabil G. Seidah et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Aprotinin and similar protease inhibitors as drugs against influenza
O. P. Zhirnov et al.
ANTIVIRAL RESEARCH (2011)
Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments
Leo A. Hardegger et al.
CHEMMEDCHEM (2011)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling
Jianing Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41
Lifeng Cai et al.
CHEMMEDCHEM (2010)
Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2
W. David Hardy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics
Gero L. Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction
Andreas Schulze et al.
JOURNAL OF VIROLOGY (2010)
Novel insights into proteolytic cleavage of influenza virus hemagglutinin
Stephanie Bertram et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme
Judith M. White et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Peptidomimetics, a synthetic tool of drug discovery
Josef Vagner et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): In search of potent SARS-CoV entry inhibitors
Ling-Hon Matthew Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Software news and updates - CHARNIM-GUI: A web-based grraphical user interface for CHARMM
Sunhwan Jo et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide
Berend Jan Bosch et al.
JOURNAL OF VIROLOGY (2008)
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide
Jan Muench et al.
CELL (2007)
Paneth cell antimicrobial peptides: Topographical distribution and quantification in human gastrointestinal tissues
Jan Wehkamp et al.
FEBS LETTERS (2006)
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
Bruno Sainz et al.
VIRUS RESEARCH (2006)
Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
Dong P. Han et al.
VIROLOGY (2006)
Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction
TY Ho et al.
ANTIVIRAL RESEARCH (2006)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library
HB Hu et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2005)
Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain
CE Yi et al.
JOURNAL OF VIROLOGY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers
S Herter et al.
BIOCHEMICAL JOURNAL (2005)
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein
S Fukushi et al.
JOURNAL OF GENERAL VIROLOGY (2005)
The FoldX web server: an online force field
J Schymkowitz et al.
NUCLEIC ACIDS RESEARCH (2005)
A heptad repeat in herpes simplex virus 1 gH, located downstream of the α-helix with attributes of a fusion peptide, is critical for virus entry and fusion
T Gianni et al.
JOURNAL OF VIROLOGY (2005)
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
H Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
WH Li et al.
EMBO JOURNAL (2005)
Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus
E Bergeron et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein
Katharine N. Bossart et al.
VIROLOGY JOURNAL (2005)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
SW Liu et al.
LANCET (2004)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Resistance to enfuvirtide, the first HIV fusion inhibitor
ML Greenberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
KH Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup A infection and identify a fusion intermediate
RC Netter et al.
JOURNAL OF VIROLOGY (2004)
Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors
JQ Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Severe acute respiratory syndrome coroavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
BJ Bosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion
CAM de Haan et al.
JOURNAL OF VIROLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor
GJ Babcock et al.
JOURNAL OF VIROLOGY (2004)
The SARS-CoV S glycoprotein: expression and functional characterization
XD Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex
BJ Bosch et al.
JOURNAL OF VIROLOGY (2003)
ZDOCK: An initial-stage protein-docking algorithm
R Chen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2003)
Novel peptide inhibitors of angiotensin-converting enzyme 2
LL Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion
EX Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
NR Labiris et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus
M Yu et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Peptides as drugs: Is there a market?
A Loffet
JOURNAL OF PEPTIDE SCIENCE (2002)
New developments in anti-HIV chemotherapy
E De Clercq
CURRENT MEDICINAL CHEMISTRY (2001)
Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2001)
Furin cleavage of the respiratory syncytial virus fusion protein is not a requirement for its transport to the surface of virus-infected cells
RJ Sugrue et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Factors and strategies for improving buccal absorption of peptides
F Veuillez et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2001)
Functional importance of the coiled-coil of the Ebola virus glycoprotein
S Watanabe et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
